The projected fair value for K&S is AU$3.98 based on Dividend Discount Model Current share price of AU$3.52 suggests K&S is potentially trading close to its fair value K&S' peers seem to be trading at ...

Beta Bionics (NASDAQ:BBNX) stock was inititaed by Baird with a Neutral rating, citing valuation concerns but highlighting the firm's growth potential. Read more here.

where n = period Calculate the 12 EMA sequentially as: Putting together the MACD requires simply doing all of the following EMA calculations for any given market instrument (a stock, future ...

Global Water Resources benefits from Arizona's demographic boom, increasing active connections and revenue. See why GWRS ...

The U.S. stock market is expected to remain volatile due to several factors. While indexes like the S&P 500 have hit record highs, market movements have been choppy due to concerns over global trade ...

The telecom provider is offering a beta service free initially, with plans to charge $15 per month. The service will also be accessible to Verizon (VZ) and AT&T (T) customers. Market Domination ...

CAE (TSE:CAE – Get Free Report) (NYSE:CAE) had its price objective lifted by research analysts at CIBC from C$37.00 to ...

IAC (NASDAQ:IAC – Get Free Report) had its price objective boosted by stock analysts at KeyCorp from $60.00 to $64.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently ...

Beta Bionics has set the terms for its plan to ... It also plans to collect an additional $17 million through a private placement of stock to investors at Wellington Management, which signed ...

Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...